Evogene Ltd.

Evogene is a leading computational biotechnology company developing novel products for life science markets through the use of a unique Computational Predictive Biology (‘CPB’) platform. The ‘CPB’ platform has been designed for the in-silico prediction and prioritization of genes, microbes and small molecules based on multiple attributes that will be key to successful development and commercialization of novel life-science based products. Successfully addressing these multiple product attributes at the beginning of the development process, ‘stage zero’, rather than one at a time, is expected to reduce the time and cost of product development, and much more importantly, increase the probability of a successful outcome.